AkbogaMKAkbogaYE. Endocan at the crossroads: a vasculoprotective molecule or inflammatory marker?. Angiology. 2019;70(7):669–70.
2.
ÇelikMSökmenESivriSUçarCNarRErerM. The relationship between serum endocan level and aortic elastic properties in patients with newly diagnosed essential hypertension. Angiology. 2019;70(7):662–8.
3.
LaurentSBoutouyriePAsmarR. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236–41.
4.
PainiABoutouyriePCalvetDTropeanoAILalouxBLaurentS. Carotid and aortic stiffness: determinants of discrepancies. Hypertension. 2006;47:371–6.
5.
YaylaKGCanpolatUYaylaÇ. A novel marker of impaired aortic elasticity in never treated hypertensive patients: monocyte/high-density lipoprotein cholesterol ratio. Acta Cardiol Sin. 2017;33:41–9.
